PHA-665752 T6128
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PHA-665752 is an effective, specific and ATP-competitive c-Met inhibitor (IC50: 9 nM), >50-fold selectivity for c-Met than STKs or RTKs.
CAS nr:
477575-56-7
Purity:
98%
Molecular Weight:
641,61
SMILES:
Cc1c([nH]c(c1C(=O)N1CCC[C@@H]1CN1CCCC1)C)/C=C\1/c2c(ccc(c2)S(=O)(=O)Cc2c(cccc2Cl)Cl)NC1=O
Formula:
C32H34Cl2N4O4S
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Autophagy,Apoptosis,Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
c-Met/HGFR,VEGFR,VEGFR,FGFR,FGFR,Autophagy,Apoptosis,Bcr-Abl,Bcr-Abl,Bcr-Abl
